- Home
- IZM vs CVKD Comparison
IZM vs CVKD Comparison
Compare IZM & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- CVKD
- Stock Information
- Founded
- IZM 2011
- CVKD 2022
- Country
- IZM China
- CVKD United States
- Employees
- IZM N/A
- CVKD N/A
- Industry
- IZM Consumer Electronics/Video Chains
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- IZM Consumer Discretionary
- CVKD Health Care
- Exchange
- IZM Nasdaq
- CVKD Nasdaq
- Market Cap
- IZM 31.8M
- CVKD 29.5M
- IPO Year
- IZM 2023
- CVKD 2023
- Fundamental
- Price
- IZM $2.51
- CVKD $11.92
- Analyst Decision
- IZM
- CVKD Strong Buy
- Analyst Count
- IZM 0
- CVKD 1
- Target Price
- IZM N/A
- CVKD $32.00
- AVG Volume (30 Days)
- IZM 31.8K
- CVKD 35.5K
- Earning Date
- IZM 07-29-2025
- CVKD 08-06-2025
- Dividend Yield
- IZM N/A
- CVKD N/A
- EPS Growth
- IZM N/A
- CVKD N/A
- EPS
- IZM N/A
- CVKD N/A
- Revenue
- IZM $180,553,977.00
- CVKD N/A
- Revenue This Year
- IZM N/A
- CVKD N/A
- Revenue Next Year
- IZM N/A
- CVKD N/A
- P/E Ratio
- IZM N/A
- CVKD N/A
- Revenue Growth
- IZM N/A
- CVKD N/A
- 52 Week Low
- IZM $1.18
- CVKD $5.70
- 52 Week High
- IZM $3.19
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- IZM 50.31
- CVKD 36.41
- Support Level
- IZM $2.50
- CVKD $11.15
- Resistance Level
- IZM $2.65
- CVKD $13.63
- Average True Range (ATR)
- IZM 0.10
- CVKD 0.99
- MACD
- IZM -0.02
- CVKD 0.01
- Stochastic Oscillator
- IZM 32.35
- CVKD 29.49
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.